| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Apogee Therapeutics, Inc.'s insiders have reduced their positions by a net 137,400 shares worth roughly $17.9M. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), APGE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 920.9K | $124.18M | - | |
| Other | 174.0K | $23.46M | -5,500 | |
| CFO | 158.4K | $21.35M | - | |
| Dir | 7.7K | $1.03M | - | |
| Dir | 7.7K | $1.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 5,500 | $134.17 | $737,935.00 | -3.2% | - | - | |
| Jul 8, 2026 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 20,000 | $133.63 | $2,672,600.00 | -2.0% | - | - | |
| Jun 22, 2026 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 80,000 | $132.54 | $10,603,200.00 | -7.3% | - | - | |
| Jun 22, 2026 | Dambkowski Carl47 | Chief Medical Officer | Sell | 26,400 | $132.60 | $3,500,640.00 | -12.8% | - | - | |
| Jun 3, 2026 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 5,500 | $78.71 | $432,905.00 | -2.6% | - | - | |
| Apr 8, 2026 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 20,000 | $82.58 | $1,651,664.00 | -0.6% | +60.7% | - | |
| Mar 25, 2026 | Henderson Jane73 | Chief Financial Officer | Sell | 2,000 | $85.00 | $170,000.00 | -1.1% | +69.2% | - | |
| Jan 14, 2026 | Henderson Michael Thomas57 | Chief Executive Officer | Sell | 20,000 | $81.11 | $1,622,159.12 | -0.3% | +4.7% | - | |
| Jan 7, 2026 | Dambkowski Carl47 | Chief Medical Officer | Sale+OE | 18,700 | $77.84 | $1,455,613.06 | -2.1% | +5.5% | - | |
| Jan 6, 2026 | Henderson Jane73 | Chief Financial Officer | Sell | 8,000 | $76.14 | $609,145.60 | -1.4% | +7.4% | - |